Open AccessAssociation of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
Author(s) -
Yunfang Yu,
Dagui Lin,
Anlin Li,
Yongjian Chen,
Qiyun Ou,
Hai Hu,
Herui Yao
Publication year - 2020
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2020.5837
Subject(s) - cohort , immune checkpoint , biomarker , oncology , medicine , immune system , immunotherapy , cancer research , immunology , biology , genetics
This cohort study investigates whether MUC16 variation could be a useful biomarker for immune checkpoint inhibitor (ICI) therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom